Age, years (SD) |
47.5 (13.9) |
44.1 (15.0) |
0.32 |
Gender male, n (%) |
24 (70.6) |
26 (65.0) |
0.61 |
Race AA, n (%) |
9 (26.4) |
13 (32.5) |
0.57 |
BMI, kg/m2 (SD) |
29.5 (5.7) |
26.2 (4.8) |
0.01 |
Living donor transplant, n (%) |
13 (38.2) |
24 (60.0) |
0.06 |
First transplant, n (%) |
29 (85.3) |
36 (90.0) |
0.72 |
Positive HCV serology, n (%) |
3 (8.8) |
3 (7.5) |
1.00 |
Family history for T2D, n (%) |
10 (29.4) |
7 (17.5) |
0.22 |
Smoking history, n (%) |
|
|
0.89 |
Never |
21 (61.8) |
24 (60.0) |
|
Former |
10 (29.4) |
11 (27.5) |
|
Current |
3 (8.8) |
5 (12.5) |
|
Renal diagnosis, n (%) |
|
|
0.49 |
APKD |
5 (15.2) |
5 (12.5) |
|
Glomerular disease |
17 (51.5) |
14 (35.0) |
|
Hypertension |
6 (17.7) |
9 (22.5) |
|
Others |
6 (18.2) |
12 (30.0) |
|
Dialysis modalities, n (%) |
|
|
0.65 |
None |
7 (20.6) |
12 (30.0) |
|
HD |
5 (14.7) |
5 (12.5) |
|
PD |
22 (64.7) |
23 (57.5) |
|
Dialysis duration, years (SD) |
3.9 (3.0) |
2.9 (2.5) |
0.17 |
Fasting glucose at transplant, mg/dl (SD) |
86.2 (9.0) |
84.6 (8.7) |
0.46 |
CNIs: CsA, n (%) |
30 (88.3) |
33 (82.5) |
0.64 |
Cumulative CNI doses, mg (SD) |
|
|
|
CsA |
41221 (13665) |
35513 (11142) |
0.07 |
Tacro |
753 (64) |
436 (66) |
0.06 |
Cumulative prednisone doses, mg (SD) |
2521 (466) |
2428 (286) |
0.30 |
Delayed graft function, n (%) |
5 (14.7) |
5 (12.5) |
0.78 |